Dongguan, China

Xinchang Liu

This inventor holds 12 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 9 EPO patents. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xinchang Liu. Retrieved from https://idiyas.com/inventor/xinchang-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 99(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Xinchang Liu: Pioneering Inventor from Dongguan

Introduction: Xinchang Liu is a renowned inventor hailing from Dongguan, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Xinchang Liu holds several patents in the areas of electronics, renewable energy, and sustainable technologies, showcasing his commitment to creating solutions for the future.

Career Highlights: With a career spanning over two decades, Xinchang Liu has worked with leading tech companies, research institutions, and universities, where he has spearheaded projects that have revolutionized the industry.

Collaborations: Xinchang Liu has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Xinchang Liu's passion for innovation, coupled with his relentless drive to push boundaries, has solidified his position as a trailblazer in the world of inventions and patents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…